Brief: Infinity Pharmaceuticals Says Selected For Addition To Nasdaq Biotechnology Index
14/12/2021 12:39
Dec 14 (Reuters) - Infinity Pharmaceuticals Inc INFI.O :
* INFINITY PHARMACEUTICALS INC - SELECTED FOR ADDITION TO
NASDAQ
BIOTECHNOLOGY INDEX EFFECTIVE AS OF MARKET OPEN ON MONDAY,
DECEMBER 20, 2021
Source text for Eikon: ID:nBwsx2V0a
Further company coverage: INFI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Infinity Pharmaceuticals
See all newsBrief: Infinity Pharmaceuticals Filed Voluntary Petition For Relief Under Provisions Of Chapter 11
Brief: Infinity Pharmaceuticals Inc Received Determination Letter From Nasdaq On September 12
Brief: Infinity Pharma Says On Sept 5, 2023, Co Received Letter From Nasdaq Notifying That Listing Of Common Stock Was Not In Compliance With Nasdaq Listing Rule
Brief: Infinity Pharmaceuticals Approved Plan To Reduce Co's Overall Headcount By 21 Positions
U.S. STOCKS ON THE MOVE-General Motors, Estee Lauder, IMAX